# FDA Inspection 1252788 - Kadlec Regional Medical Center - October 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/kadlec-regional-medical-center/bbec5dac-83c7-408c-8a6b-75dd068dddd6
Source feed: FDA_Inspections

> FDA Inspection 1252788 for Kadlec Regional Medical Center on October 22, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252788
- Company Name: Kadlec Regional Medical Center
- Inspection Date: 2024-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252788 - 2024-10-22](https://www.keypedia.com/records/fda_inspections/kadlec-regional-medical-center/ece30818-9664-4671-a85d-0a5897342db4)
- [FDA Inspection 1095046 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/kadlec-regional-medical-center/34154eac-a507-4945-ba9b-fcecaddf84a3)
- [FDA Inspection 1016461 - 2017-06-05](https://www.keypedia.com/records/fda_inspections/kadlec-regional-medical-center/7c7867d3-d418-412e-bb08-651cfaac17d5)
- [FDA Inspection 906514 - 2014-12-03](https://www.keypedia.com/records/fda_inspections/kadlec-regional-medical-center/5b2e69ee-aecb-4f95-805e-3d3fccce82c0)

Company: https://www.keypedia.com/companies/kadlec-regional-medical-center/608b74a2-820b-4789-b0a5-23c42f200450

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d